Emerging evidence suggests that SLK plays important roles in cancer; for instance, loss of SLK in a murine model of HER2/Neu-positive breast cancers accelerates tumour onset and decreases overall survival (27). This evidence concerns the gene ERBB2 and breast carcinoma.